• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索口腔微生物组生物标志物在结直肠癌诊断和预后中的潜力:一项系统综述

Exploring the Potential of Oral Microbiome Biomarkers for Colorectal Cancer Diagnosis and Prognosis: A Systematic Review.

作者信息

Negrut Roxana Loriana, Cote Adrian, Maghiar Adrian Marius

机构信息

Department Medicine, Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.

County Clinical Emergency Hospital Bihor, 410087 Oradea, Romania.

出版信息

Microorganisms. 2023 Jun 15;11(6):1586. doi: 10.3390/microorganisms11061586.

DOI:10.3390/microorganisms11061586
PMID:37375087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10305386/
Abstract

There is growing evidence indicating that the oral microbiota, specifically certain periodontopathogens such as , may play a role in the development of colorectal cancer and that it could potentially be used as a biomarker for diagnosing colorectal cancer (CRC). The question beneath this systematic review is whether the development or progression of colorectal cancer can be attributed to the presence of certain oral bacteria, which could be used for discovering non-invasive biomarkers for CRC. This review aims to give an overview of the actual status of published studies regarding the oral pathogens related to colorectal cancer and assess the effectiveness of the oral microbiome derived biomarkers. A systematic literature search was performed using four databases, Web of Science, Scopus, PubMed, and Science Direct, on the 3rd and 4th of March 2023. The studies that did not have matching inclusion/exclusion criteria were winnowed out. A total of fourteen studies were included. The risk of bias was performed by using QUADAS-2. After assessing the studies, the general conclusion is that oral microbiota-based biomarkers can become a promising non-invasive tool for detecting CRC, but further research is needed in order to determine the mechanisms of oral dysbiosis in colorectal carcinogenesis.

摘要

越来越多的证据表明,口腔微生物群,特别是某些牙周病原体,如……,可能在结直肠癌的发生发展中起作用,并且有可能被用作诊断结直肠癌(CRC)的生物标志物。本系统评价背后的问题是,结直肠癌的发生或进展是否可归因于某些口腔细菌的存在,而这些细菌可用于发现CRC的非侵入性生物标志物。本综述旨在概述已发表的关于与结直肠癌相关的口腔病原体的研究现状,并评估源自口腔微生物群的生物标志物的有效性。2023年3月3日和4日,使用Web of Science、Scopus、PubMed和Science Direct这四个数据库进行了系统的文献检索。剔除了不符合纳入/排除标准的研究。共纳入14项研究。使用QUADAS-2进行偏倚风险评估。在对这些研究进行评估后,总体结论是,基于口腔微生物群的生物标志物可以成为一种有前景的检测CRC的非侵入性工具,但需要进一步研究以确定口腔生态失调在结直肠癌发生中的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e8/10305386/78b7b3ad81ce/microorganisms-11-01586-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e8/10305386/fdf42fc5e0dc/microorganisms-11-01586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e8/10305386/78b7b3ad81ce/microorganisms-11-01586-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e8/10305386/fdf42fc5e0dc/microorganisms-11-01586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e8/10305386/78b7b3ad81ce/microorganisms-11-01586-g002.jpg

相似文献

1
Exploring the Potential of Oral Microbiome Biomarkers for Colorectal Cancer Diagnosis and Prognosis: A Systematic Review.探索口腔微生物组生物标志物在结直肠癌诊断和预后中的潜力:一项系统综述
Microorganisms. 2023 Jun 15;11(6):1586. doi: 10.3390/microorganisms11061586.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.用于早期结直肠癌检测的微生物组衍生生物标志物的系统评价。
Neoplasia. 2023 Feb;36:100868. doi: 10.1016/j.neo.2022.100868. Epub 2022 Dec 23.
4
Relationship between oral microbiota and colorectal cancer: A systematic review.口腔微生物群与结直肠癌的关系:一项系统综述。
J Periodontal Res. 2024 Dec;59(6):1071-1082. doi: 10.1111/jre.13289. Epub 2024 May 22.
5
The Association of Oral Microbiome Dysbiosis with Gastrointestinal Cancers and Its Diagnostic Efficacy.口腔微生物失调与胃肠道癌症的关联及其诊断效果。
J Gastrointest Cancer. 2023 Dec;54(4):1082-1101. doi: 10.1007/s12029-022-00901-4. Epub 2023 Jan 5.
6
Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.人类口腔微生物组失调作为一种新型非侵入性生物标志物在结直肠癌检测中的应用。
Theranostics. 2020 Sep 18;10(25):11595-11606. doi: 10.7150/thno.49515. eCollection 2020.
7
The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.具核梭杆菌在结直肠癌发生中的作用。
Pathobiology. 2021;88(2):127-140. doi: 10.1159/000512175. Epub 2020 Dec 8.
8
Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.具核梭杆菌,结直肠癌的关键致病因子和微生物生物标志物。
Trends Microbiol. 2023 Feb;31(2):159-172. doi: 10.1016/j.tim.2022.08.010. Epub 2022 Sep 1.
9
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences.微生物群与结直肠癌发生:相关机制及种族差异
World J Gastrointest Oncol. 2022 Feb 15;14(2):375-395. doi: 10.4251/wjgo.v14.i2.375.
10
Diagnostic Performance of Intestinal in Colorectal Cancer: A Meta-Analysis.结直肠癌中肠道 的诊断性能:一项荟萃分析。
Chin Med J (Engl). 2018 Jun 5;131(11):1349-1356. doi: 10.4103/0366-6999.232814.

引用本文的文献

1
Periodontitis Frequently Exists in Patients with Colorectal Carcinoma and Causes Supplementary Impairment of Insulin Resistance.牙周炎在结直肠癌患者中经常存在,并导致胰岛素抵抗的额外损害。
Metabolites. 2025 Jun 19;15(6):414. doi: 10.3390/metabo15060414.
2
Enterobacterales abundance in oral cancer patients and elevated clindamycin resistance rates in head and neck infections at a Hungarian Tertiary Hospital.匈牙利一家三级医院口腔癌患者中肠杆菌目细菌的丰度以及头颈部感染中克林霉素耐药率升高。
Ann Clin Microbiol Antimicrob. 2025 May 29;24(1):33. doi: 10.1186/s12941-025-00802-x.
3
Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease.

本文引用的文献

1
Oral Microbiota as Novel Biomarkers for Colorectal Cancer Screening.口腔微生物群作为结直肠癌筛查的新型生物标志物
Cancers (Basel). 2022 Dec 28;15(1):192. doi: 10.3390/cancers15010192.
2
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.用于早期结直肠癌检测的微生物组衍生生物标志物的系统评价。
Neoplasia. 2023 Feb;36:100868. doi: 10.1016/j.neo.2022.100868. Epub 2022 Dec 23.
3
Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients.越南结直肠癌患者的肿瘤微生物组和梭杆菌基因组学。
胃肠道疾病中的微生物组标志物:炎症性肠病、结直肠癌和乳糜泻
Int J Mol Sci. 2025 May 17;26(10):4818. doi: 10.3390/ijms26104818.
4
Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling.微生物群作为诊断生物标志物:通过微生物组分析推进早期癌症检测和个性化治疗方法。
Front Immunol. 2025 May 8;16:1559480. doi: 10.3389/fimmu.2025.1559480. eCollection 2025.
5
Unveiling the microbial orchestra: exploring the role of microbiota in cancer development and treatment.揭开微生物的“管弦乐队”之谜:探索微生物群在癌症发生发展及治疗中的作用。
Discov Oncol. 2025 Apr 30;16(1):646. doi: 10.1007/s12672-025-02352-2.
6
Periodontal bacteria influence systemic diseases through the gut microbiota.牙周细菌通过肠道微生物群影响全身疾病。
Front Cell Infect Microbiol. 2024 Nov 15;14:1478362. doi: 10.3389/fcimb.2024.1478362. eCollection 2024.
7
Cancer and the Microbiome of the Human Body.癌症与人体微生物组。
Nutrients. 2024 Aug 21;16(16):2790. doi: 10.3390/nu16162790.
8
Gut Microbiota and Colorectal Cancer: An Umbrella Review of Methodological Trends and Clinical Correlations.肠道微生物群与结直肠癌:方法学趋势和临床相关性的综合综述
Cureus. 2024 Feb 14;16(2):e54210. doi: 10.7759/cureus.54210. eCollection 2024 Feb.
9
Bridging the gap between omics research and dental practice.弥合组学研究与牙科实践之间的差距。
BDJ Open. 2024 Mar 4;10(1):16. doi: 10.1038/s41405-024-00199-3.
10
The role of microbiomes in gastrointestinal cancers: new insights.微生物群落在胃肠道癌症中的作用:新见解
Front Oncol. 2024 Feb 1;13:1344328. doi: 10.3389/fonc.2023.1344328. eCollection 2023.
NPJ Biofilms Microbiomes. 2022 Oct 29;8(1):87. doi: 10.1038/s41522-022-00351-7.
4
Salivary serves as a potential biomarker for colorectal cancer.唾液可作为结直肠癌的一种潜在生物标志物。
iScience. 2022 Apr 4;25(5):104203. doi: 10.1016/j.isci.2022.104203. eCollection 2022 May 20.
5
Investigation of Fusobacterium Nucleatum in saliva and colorectal mucosa: a pilot study.口腔唾液和结直肠黏膜中具核梭杆菌的研究:一项初步研究。
Sci Rep. 2022 Apr 4;12(1):5622. doi: 10.1038/s41598-022-09587-x.
6
Colorectal Cancer Patients Have Four Specific Bacterial Species in Oral and Gut Microbiota in Common-A Metagenomic Comparison with Healthy Subjects.结直肠癌患者口腔和肠道微生物群中共有四种特定细菌物种——与健康受试者的宏基因组比较
Cancers (Basel). 2021 Jul 2;13(13):3332. doi: 10.3390/cancers13133332.
7
The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome.饮食治疗干预对代谢综合征患者肌肉减少症指数的影响。
Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):470-478. doi: 10.4183/aeb.2020.470.
8
Alterations in the oral and gut microbiome of colorectal cancer patients and association with host clinical factors.结直肠癌患者口腔和肠道微生物群的改变及其与宿主临床因素的关联。
Int J Cancer. 2021 Apr 12. doi: 10.1002/ijc.33596.
9
The Potential of Colonic Tumor Tissue to Predict Staging and Its Interplay with Oral Abundance in Colon Cancer Patients.结肠癌患者结肠肿瘤组织预测分期的潜力及其与口腔微生物丰度的相互作用。
Cancers (Basel). 2021 Mar 1;13(5):1032. doi: 10.3390/cancers13051032.
10
Bacterial community structure alterations within the colorectal cancer gut microbiome.结直肠癌肠道微生物组中细菌群落结构的改变。
BMC Microbiol. 2021 Mar 31;21(1):98. doi: 10.1186/s12866-021-02153-x.